论文部分内容阅读
目的:探讨深层巩膜和狄氏膜切灼联合前房注气术治疗青光眼和难治性青光眼的临床疗效。方法:采用深层巩膜和狄氏膜切灼联合前房注气术对完成追踪观察的102例111眼青光眼和难治性青光眼进行治疗。结果:术后随访18～36(平均21.5)mo术后眼压比术前下降,青光眼手术前和手术后眼压差异均有统计学意义。功能性滤过泡形成率为95.5%。结论:深层巩膜和狄氏膜切灼术联合前房注气术治疗各种类型青光眼安全而有效。
Objective: To investigate the clinical effects of deep sclera and pedicel cutting combined with anterior chamber insufflation for the treatment of glaucoma and refractory glaucoma. Methods: 102 cases of 111 glaucoma and refractory glaucoma who underwent follow-up observation were treated with deep sclera and pedicel cutting and anterior chamber gas injection. Results: The intraocular pressure (IOP) decreased from 18 to 36 (mean 21.5) months after operation, and there was significant difference between preoperative and postoperative IOP in glaucoma. The functional filter bleb formation rate was 95.5%. CONCLUSIONS: Deep sclera and pedicel ablation combined with anterior chamber insufflation are safe and effective in treating various types of glaucoma.